Breaking News: Eton Pharmaceuticals Receives FDA Approval for Dehydrated Alcohol Injection NDA Response – What This Means for the Medical Industry
Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection DEER PARK, Ill., Jan. 11, 2023 (GLOBE NEWSWIRE) — Eton Pharmaceuticals Product previously granted orphan drug designation for methanol poisoning Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced…